COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday.
The comments were made in documents posted ahead of Thursday's meeting of a panel of FDA's independent experts, who are expected to make recommendations on what strain an updated COVID-19 booster should target.
Last year's COVID vaccine boosters in the United States featured both the original strain of the vaccine and Omicron in a so-called bivalent shot. COVID-related deaths in the United States spiked in January, but have mostly fallen since then. They fell 14.3% in the past week."There is no indication that SARS-CoV-2 evolution is slowing down, though immunity appears to be mitigating severe clinical outcomes," the FDA's staff said.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff saysVaccine manufacturers Pfizer, Moderna and Novavax will be expected to update their shots according to the strain the FDA selects for the fall.
Read more »
How Man City 2023 stack up against Guardiola's 2009 BarcelonaPep Guardiola became the first manager in Europe to win two trebles as Manchester City completed a dream season by beating Inter Milan 1-0 to secure their first Champions League title on Saturday.
Read more »
11 Best-Dressed Stars Who Attended The 2023 Cannes Film Festival11 Best-Dressed Stars Who Attended The 2023 Cannes Film Festival
Read more »
Wall Street economists are increasingly less worried about a 2023 recession'While we still expect the delayed effects of monetary tightening and tighter credit availability to dampen economic growth, the economy has proven to be more resilient than we anticipated,' Wells Fargo economists said.
Read more »